GHIT Fund

GHIT Fund commits JPY 1.06bn to nine disease R&D projects

TOKYO – October 29, 2026 -- The Global Health Innovative Technology (GHIT) Fund has committed about JPY 1.06 billion (USD 6.8 million) to nine R&D projects covering drugs, vaccines and diagnostics for malaria, neglected tropical diseases (NTDs) and emerging infectious diseases such as Ebola.

Trachoma rapid test receives JPY 450 million for clinical validation and launch

The largest single award, about JPY 450 million (USD 2.9 million), goes to a point-of-care rapid diagnostic test for trachoma. The project is led by Drugs and Diagnostics for Tropical Diseases, Medical & Biological Laboratories (MBL), The Carter Center and Big Eye Diagnostics, and has received GHIT support since 2024.

GHIT Fund Launches NTDpedia to Drive R&D Funding for 1.5 Billion People

Tokyo – September 19, 2026 -- The Global Health Innovative Technology (GHIT) Fund has launched NTDpedia, a digital encyclopedia targeting the awareness gap that keeps neglected tropical diseases (NTDs) underfunded despite affecting 1.5 billion people worldwide.

GHIT Fund targets awareness gap as root cause of NTD underfunding

The platform, titled "NTDpedia: Your Guide to Neglected Tropical Diseases," is designed as an accessible digital resource covering all 21 disease groups recognized by the World Health Organization, including viral, bacterial, parasitic, and fungal infections, snakebite envenoming, and noma. Supervised by Prof. Kenji Hirayama of Nagasaki University, the site aims to make complex health issues understandable to a general audience, including students, teachers, companies, and advocates.